-
1
-
-
33749624177
-
Cancer regression in patients after transfer of genetically engineered lymphocytes
-
Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006;314:126-29.
-
(2006)
Science
, vol.314
, pp. 126-129
-
-
Morgan, R.A.1
Dudley, M.E.2
Wunderlich, J.R.3
Hughes, M.S.4
Yang, J.C.5
Sherry, R.M.6
-
2
-
-
70149114880
-
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
-
Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, Hughes MS, et al. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 2009;114:535-46.
-
(2009)
Blood
, vol.114
, pp. 535-546
-
-
Johnson, L.A.1
Morgan, R.A.2
Dudley, M.E.3
Cassard, L.4
Yang, J.C.5
Hughes, M.S.6
-
3
-
-
77957756405
-
Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells
-
Kochenderfer JN, Yu Z, Frasheri D, Restifo NP, Rosenberg SA. Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells. Blood 2010;116:3875-86.
-
(2010)
Blood
, vol.116
, pp. 3875-3886
-
-
Kochenderfer, J.N.1
Yu, Z.2
Frasheri, D.3
Restifo, N.P.4
Rosenberg, S.A.5
-
4
-
-
77955510549
-
Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans
-
Jensen MC, Popplewell L, Cooper LJ, DiGiusto D, Kalos M, Ostberg JR, et al. Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans. Biol Blood Marrow Transplant 2010;16:1245-56.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 1245-1256
-
-
Jensen, M.C.1
Popplewell, L.2
Cooper, L.J.3
DiGiusto, D.4
Kalos, M.5
Ostberg, J.R.6
-
5
-
-
79952187823
-
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis
-
Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan DA, Feldman SA, et al. T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther 2011;19:620-26.
-
(2011)
Mol Ther
, vol.19
, pp. 620-626
-
-
Parkhurst, M.R.1
Yang, J.C.2
Langan, R.C.3
Dudley, M.E.4
Nathan, D.A.5
Feldman, S.A.6
-
6
-
-
80455179612
-
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
-
Brentjens RJ, Riviere I, Park JH, Davila ML, Wang X, Stefanski J, et al. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood 2011;118:4817-28.
-
(2011)
Blood
, vol.118
, pp. 4817-4828
-
-
Brentjens, R.J.1
Riviere, I.2
Park, J.H.3
Davila, M.L.4
Wang, X.5
Stefanski, J.6
-
7
-
-
84897557033
-
Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset composition
-
Riddell SR, Sommermeyer D, Berger C, Liu LS, Balakrishnan A, Salter A, et al. Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset composition. Cancer J 2014;20:141-44.
-
(2014)
Cancer J
, vol.20
, pp. 141-144
-
-
Riddell, S.R.1
Sommermeyer, D.2
Berger, C.3
Liu, L.S.4
Balakrishnan, A.5
Salter, A.6
-
8
-
-
77950475517
-
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2
-
Morgan RA, Yang JC, Kitano M, Dudley ME, Laurencot CM, Rosenberg SA. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther 2010;18:843-51.
-
(2010)
Mol Ther
, vol.18
, pp. 843-851
-
-
Morgan, R.A.1
Yang, J.C.2
Kitano, M.3
Dudley, M.E.4
Laurencot, C.M.5
Rosenberg, S.A.6
-
9
-
-
84873991752
-
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy
-
Morgan RA, Chinnasamy N, Abate-Daga D, Gros A, Robbins PF, Zheng Z, et al. Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J Immunother 2013;36:133-51.
-
(2013)
J Immunother
, vol.36
, pp. 133-151
-
-
Morgan, R.A.1
Chinnasamy, N.2
Abate-Daga, D.3
Gros, A.4
Robbins, P.F.5
Zheng, Z.6
-
10
-
-
79951848084
-
Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases
-
Corbiere V, Chapiro J, Stroobant V, Ma W, Lurquin C, Lethe B, et al. Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases. Cancer Res 2011;71:1253-62.
-
(2011)
Cancer Res
, vol.71
, pp. 1253-1262
-
-
Corbiere, V.1
Chapiro, J.2
Stroobant, V.3
Ma, W.4
Lurquin, C.5
Lethe, B.6
-
11
-
-
84880276438
-
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
-
Robbins PF, Lu YC, El-Gamil M, Li YF, Gross C, Gartner J, et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat Med 2013;19:747-52.
-
(2013)
Nat Med
, vol.19
, pp. 747-752
-
-
Robbins, P.F.1
Lu, Y.C.2
El-Gamil, M.3
Li, Y.F.4
Gross, C.5
Gartner, J.6
-
12
-
-
84903846565
-
Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions
-
Lu YC, Yao X, Crystal JS, Li YF, El-Gamil M, Gross C, et al. Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions. Clin Cancer Res 2014;20:3401-10.
-
(2014)
Clin Cancer Res
, vol.20
, pp. 3401-3410
-
-
Lu, Y.C.1
Yao, X.2
Crystal, J.S.3
Li, Y.F.4
El-Gamil, M.5
Gross, C.6
-
13
-
-
84900301377
-
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer
-
Tran E, Turcotte S, Gros A, Robbins PF, Lu YC, Dudley ME, et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science 2014;344:641-45.
-
(2014)
Science
, vol.344
, pp. 641-645
-
-
Tran, E.1
Turcotte, S.2
Gros, A.3
Robbins, P.F.4
Lu, Y.C.5
Dudley, M.E.6
-
14
-
-
0344247505
-
cDNA sequences of two inducible T-cell genes
-
Kwon BS, Weissman SM. cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci U S A 1989;86:1963-67.
-
(1989)
Proc Natl Acad Sci U S A
, vol.86
, pp. 1963-1967
-
-
Kwon, B.S.1
Weissman, S.M.2
-
15
-
-
17644389199
-
TNF/TNFR family members in costimulation of T cell responses
-
Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005;23:23-68.
-
(2005)
Annu Rev Immunol
, vol.23
, pp. 23-68
-
-
Watts, T.H.1
-
16
-
-
0037094139
-
4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function
-
Wen T, Bukczynski J, Watts TH. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function. J Immunol 2002;168:4897-906.
-
(2002)
J Immunol
, vol.168
, pp. 4897-4906
-
-
Wen, T.1
Bukczynski, J.2
Watts, T.H.3
-
17
-
-
0036838689
-
4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1
-
Lee HW, Park SJ, Choi BK, Kim HH, Nam KO, Kwon BS. 4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1. J Immunol 2002;169:4882-88.
-
(2002)
J Immunol
, vol.169
, pp. 4882-4888
-
-
Lee, H.W.1
Park, S.J.2
Choi, B.K.3
Kim, H.H.4
Nam, K.O.5
Kwon, B.S.6
-
18
-
-
0036075444
-
In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses
-
Halstead ES, Mueller YM, Altman JD, Katsikis PD. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat Immunol 2002;3:536-41.
-
(2002)
Nat Immunol
, vol.3
, pp. 536-541
-
-
Halstead, E.S.1
Mueller, Y.M.2
Altman, J.D.3
Katsikis, P.D.4
-
19
-
-
1642314780
-
Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo
-
Dawicki W, Watts TH. Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo. Eur J Immunol 2004;34:743-51.
-
(2004)
Eur J Immunol
, vol.34
, pp. 743-751
-
-
Dawicki, W.1
Watts, T.H.2
-
20
-
-
34347398235
-
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities
-
Wolfl M, Kuball J, Ho WY, Nguyen H, Manley TJ, Bleakley M, et al. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 2007;110:201-10.
-
(2007)
Blood
, vol.110
, pp. 201-210
-
-
Wolfl, M.1
Kuball, J.2
Ho, W.Y.3
Nguyen, H.4
Manley, T.J.5
Bleakley, M.6
-
21
-
-
84892164928
-
CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor
-
Ye Q, Song DG, Poussin M, Yamamoto T, Best A, Li C, et al. CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor. Clin Cancer Res 2014;20:44-55.
-
(2014)
Clin Cancer Res
, vol.20
, pp. 44-55
-
-
Ye, Q.1
Song, D.G.2
Poussin, M.3
Yamamoto, T.4
Best, A.5
Li, C.6
-
22
-
-
60049085293
-
CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy
-
Watanabe K, Suzuki S, Kamei M, Toji S, Kawase T, Takahashi T, et al. CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy. Int J Hematol 2008;88:311-20.
-
(2008)
Int J Hematol
, vol.88
, pp. 311-320
-
-
Watanabe, K.1
Suzuki, S.2
Kamei, M.3
Toji, S.4
Kawase, T.5
Takahashi, T.6
-
23
-
-
79953063320
-
Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation
-
Zandvliet ML, van LE, Jedema I, Kruithof S, Kester MG, Guchelaar HJ, et al. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation. J Immunother 2011;34:307-19.
-
(2011)
J Immunother
, vol.34
, pp. 307-319
-
-
Zandvliet, M.L.1
Van, L.E.2
Jedema, I.3
Kruithof, S.4
Kester, M.G.5
Guchelaar, H.J.6
-
24
-
-
55949097109
-
Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities
-
Wolfl M, Kuball J, Eyrich M, Schlegel PG, Greenberg PD. Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities. Cytometry A 2008;73:1043-49.
-
(2008)
Cytometry A
, vol.73
, pp. 1043-1049
-
-
Wolfl, M.1
Kuball, J.2
Eyrich, M.3
Schlegel, P.G.4
Greenberg, P.D.5
-
25
-
-
84899748384
-
PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors
-
Gros A, RobbinsPF, Yao X, LiYF, Turcotte S, Tran E, etal. PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors. J Clin Invest 2014;124:2246-59.
-
(2014)
J Clin Invest
, vol.124
, pp. 2246-2259
-
-
Gros, A.1
Robbins, P.F.2
Yao, X.3
Li, Y.F.4
Turcotte, S.5
Tran, E.6
-
26
-
-
77957731999
-
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma
-
Jones S, Wang TL, Shih I, Mao TL, Nakayama K, Roden R, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010;330:228-31.
-
(2010)
Science
, vol.330
, pp. 228-231
-
-
Jones, S.1
Wang, T.L.2
Shih, I.3
Mao, T.L.4
Nakayama, K.5
Roden, R.6
-
27
-
-
84959152038
-
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
-
Gros A, Parkhurst MR, Tran E, Pasetto A, Robbins PF, Ilyas S, et al. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. Nat Med 2016;22:433-8.
-
(2016)
Nat Med
, vol.22
, pp. 433-438
-
-
Gros, A.1
Parkhurst, M.R.2
Tran, E.3
Pasetto, A.4
Robbins, P.F.5
Ilyas, S.6
-
28
-
-
84943329717
-
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
-
Cohen CJ, Gartner JJ, Horovitz-Fried M, Shamalov K, Trebska-McGowan K, Bliskovsky VV, et al. Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes. J Clin Invest 2015;125:3981-91.
-
(2015)
J Clin Invest
, vol.125
, pp. 3981-3991
-
-
Cohen, C.J.1
Gartner, J.J.2
Horovitz-Fried, M.3
Shamalov, K.4
Trebska-McGowan, K.5
Bliskovsky, V.V.6
-
29
-
-
84863338541
-
Simplifiedmethodof thegrowthof humantumorinfiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment
-
Jin J, Sabatino M, Somerville R, Wilson JR, Dudley ME, Stroncek DF, et al. Simplifiedmethodof thegrowthof humantumorinfiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment. J Immunother 2012;35:283-92.
-
(2012)
J Immunother
, vol.35
, pp. 283-292
-
-
Jin, J.1
Sabatino, M.2
Somerville, R.3
Wilson, J.R.4
Dudley, M.E.5
Stroncek, D.F.6
-
30
-
-
84864424747
-
Immune epitope database analysis resource
-
Kim Y, Ponomarenko J, Zhu Z, Tamang D, Wang P, Greenbaum J, et al. Immune epitope database analysis resource. Nucleic Acids Res 2012;40:W525-W30.
-
(2012)
Nucleic Acids Res
, vol.40
, pp. W525-W530
-
-
Kim, Y.1
Ponomarenko, J.2
Zhu, Z.3
Tamang, D.4
Wang, P.5
Greenbaum, J.6
-
31
-
-
2442499729
-
Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach
-
Nielsen M, Lundegaard C, Worning P, Hvid CS, Lamberth K, Buus S, et al. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics 2004;20:1388-97.
-
(2004)
Bioinformatics
, vol.20
, pp. 1388-1397
-
-
Nielsen, M.1
Lundegaard, C.2
Worning, P.3
Hvid, C.S.4
Lamberth, K.5
Buus, S.6
-
32
-
-
48449106045
-
NetMHC-3.0: Accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11
-
Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, Nielsen M. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res 2008;36:W509-W12.
-
(2008)
Nucleic Acids Res
, vol.36
, pp. W509-W512
-
-
Lundegaard, C.1
Lamberth, K.2
Harndahl, M.3
Buus, S.4
Lund, O.5
Nielsen, M.6
-
33
-
-
25444476693
-
Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method
-
Peters B, Sette A. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 2005;6:132.
-
(2005)
BMC Bioinformatics
, vol.6
, pp. 132
-
-
Peters, B.1
Sette, A.2
-
34
-
-
39549085122
-
Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries
-
Sidney J, Assarsson E, Moore C, Ngo S, Pinilla C, Sette A, et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res 2008;4:2.
-
(2008)
Immunome Res
, vol.4
, pp. 2
-
-
Sidney, J.1
Assarsson, E.2
Moore, C.3
Ngo, S.4
Pinilla, C.5
Sette, A.6
-
35
-
-
84949730499
-
Immunogenicity of somatic mutations in human gastrointestinal cancers
-
Tran E, Ahmadzadeh M, Lu YC, Gros A, Turcotte S, Robbins PF, et al. Immunogenicity of somatic mutations in human gastrointestinal cancers. Science 2015;350:1387-90.
-
(2015)
Science
, vol.350
, pp. 1387-1390
-
-
Tran, E.1
Ahmadzadeh, M.2
Lu, Y.C.3
Gros, A.4
Turcotte, S.5
Robbins, P.F.6
-
36
-
-
84939812788
-
High-throughput pairing of T cell receptor alpha and beta sequences
-
Howie B, Sherwood AM, Berkebile AD, Berka J, Emerson RO, Williamson DW, et al. High-throughput pairing of T cell receptor alpha and beta sequences. Sci Transl Med 2015;7:301ra131.
-
(2015)
Sci Transl Med
, vol.7
, pp. 301ra131
-
-
Howie, B.1
Sherwood, A.M.2
Berkebile, A.D.3
Berka, J.4
Emerson, R.O.5
Williamson, D.W.6
-
37
-
-
85016143090
-
Tumor- and neoantigen-reactive T-cell receptors can be identified based on their frequency in fresh tumor
-
Pasetto A, Alena G, Robbins PF, Deniger DC, Prickett TD, Matus-Nicodemos R, et al. Tumor- and neoantigen-reactive T-cell receptors can be identified based on their frequency in fresh tumor. Cancer Immunol Res 2016;4:734-43.
-
(2016)
Cancer Immunol Res
, vol.4
, pp. 734-743
-
-
Pasetto, A.1
Alena, G.2
Robbins, P.F.3
Deniger, D.C.4
Prickett, T.D.5
Matus-Nicodemos, R.6
-
38
-
-
84876862578
-
MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy
-
Dossinger G, Bunse M, Bet J, Albrecht J, Paszkiewicz PJ, Weissbrich B, et al. MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy. PLoS One 2013;8:e61384.
-
(2013)
PLoS One
, vol.8
-
-
Dossinger, G.1
Bunse, M.2
Bet, J.3
Albrecht, J.4
Paszkiewicz, P.J.5
Weissbrich, B.6
-
39
-
-
84887445200
-
A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days
-
Kobayashi E, Mizukoshi E, Kishi H, Ozawa T, Hamana H, Nagai T, et al. A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days. Nat Med 2013;19:1542-46.
-
(2013)
Nat Med
, vol.19
, pp. 1542-1546
-
-
Kobayashi, E.1
Mizukoshi, E.2
Kishi, H.3
Ozawa, T.4
Hamana, H.5
Nagai, T.6
-
40
-
-
33749005425
-
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability
-
Cohen CJ, Zhao Y, Zheng Z, Rosenberg SA, Morgan RA. Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. Cancer Res 2006;66:8878-86.
-
(2006)
Cancer Res
, vol.66
, pp. 8878-8886
-
-
Cohen, C.J.1
Zhao, Y.2
Zheng, Z.3
Rosenberg, S.A.4
Morgan, R.A.5
-
41
-
-
34248595961
-
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond
-
Cohen CJ, Li YF, El-Gamil M, Robbins PF, Rosenberg SA, Morgan RA. Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. Cancer Res 2007;67:3898-903.
-
(2007)
Cancer Res
, vol.67
, pp. 3898-3903
-
-
Cohen, C.J.1
Li, Y.F.2
El-Gamil, M.3
Robbins, P.F.4
Rosenberg, S.A.5
Morgan, R.A.6
-
42
-
-
84862077998
-
Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity
-
Haga-Friedman A, Horovitz-Fried M, Cohen CJ. Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity. J Immunol 2012;188:5538-46.
-
(2012)
J Immunol
, vol.188
, pp. 5538-5546
-
-
Haga-Friedman, A.1
Horovitz-Fried, M.2
Cohen, C.J.3
-
43
-
-
79251588743
-
A TCR targeting the HLA-A∗ 0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer
-
Chinnasamy N, Wargo JA, Yu Z, Rao M, Frankel TL, Riley JP, et al. A TCR targeting the HLA-A∗ 0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer. J Immunol 2011;186:685-96.
-
(2011)
J Immunol
, vol.186
, pp. 685-696
-
-
Chinnasamy, N.1
Wargo, J.A.2
Yu, Z.3
Rao, M.4
Frankel, T.L.5
Riley, J.P.6
-
44
-
-
33750324618
-
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes
-
Johnson LA, Heemskerk B, Powell DJJr, Cohen CJ, Morgan RA, Dudley ME, et al. Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes. J Immunol 2006;177:6548-59.
-
(2006)
J Immunol
, vol.177
, pp. 6548-6559
-
-
Johnson, L.A.1
Heemskerk, B.2
Powell, D.J.3
Cohen, C.J.4
Morgan, R.A.5
Dudley, M.E.6
-
45
-
-
0042834246
-
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens
-
Morgan RA, Dudley ME, Yu YY, Zheng Z, Robbins PF, Theoret MR, et al. High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens. J Immunol 2003;171:3287-95.
-
(2003)
J Immunol
, vol.171
, pp. 3287-3295
-
-
Morgan, R.A.1
Dudley, M.E.2
Yu, Y.Y.3
Zheng, Z.4
Robbins, P.F.5
Theoret, M.R.6
-
46
-
-
84866735170
-
Paths to stemness: Building the ultimate antitumour T cell
-
Gattinoni L, Klebanoff CA, Restifo NP. Paths to stemness: building the ultimate antitumour T cell. Nat Rev Cancer 2012;12:671-84.
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 671-684
-
-
Gattinoni, L.1
Klebanoff, C.A.2
Restifo, N.P.3
-
47
-
-
70350458112
-
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
-
Hinrichs CS, Borman ZA, Cassard L, Gattinoni L, Spolski R, Yu Z, et al. Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity. Proc Natl Acad Sci U S A 2009;106:17469-74.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 17469-17474
-
-
Hinrichs, C.S.1
Borman, Z.A.2
Cassard, L.3
Gattinoni, L.4
Spolski, R.5
Yu, Z.6
-
48
-
-
80051698813
-
Determinants of successful CD8+ T-cell adoptive immunotherapy forlarge established tumors in mice
-
Klebanoff CA, Gattinoni L, Palmer DC, Muranski P, Ji Y, Hinrichs CS, et al. Determinants of successful CD8+ T-cell adoptive immunotherapy forlarge established tumors in mice. Clin Cancer Res 2011;17:5343-52.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 5343-5352
-
-
Klebanoff, C.A.1
Gattinoni, L.2
Palmer, D.C.3
Muranski, P.4
Ji, Y.5
Hinrichs, C.S.6
-
49
-
-
78751689288
-
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy
-
Hinrichs CS, Borman ZA, Gattinoni L, Yu Z, Burns WR, Huang J, et al. Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. Blood 2011;117:808-14.
-
(2011)
Blood
, vol.117
, pp. 808-814
-
-
Hinrichs, C.S.1
Borman, Z.A.2
Gattinoni, L.3
Yu, Z.4
Burns, W.R.5
Huang, J.6
-
50
-
-
0036857654
-
Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens
-
Trautmann L, Labarriere N, Jotereau F, Karanikas V, Gervois N, Connerotte T, et al. Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. Eur J Immunol 2002;32:3181-90.
-
(2002)
Eur J Immunol
, vol.32
, pp. 3181-3190
-
-
Trautmann, L.1
Labarriere, N.2
Jotereau, F.3
Karanikas, V.4
Gervois, N.5
Connerotte, T.6
-
51
-
-
0036883963
-
Dominant TCR-alpha requirements for a self antigen recognition in humans
-
Mantovani S, Palermo B, Garbelli S, Campanelli R, Robustelli Della Cuna G, Gennari R, et al. Dominant TCR-alpha requirements for a self antigen recognition in humans. J Immunol 2002;169:6253-60.
-
(2002)
J Immunol
, vol.169
, pp. 6253-6260
-
-
Mantovani, S.1
Palermo, B.2
Garbelli, S.3
Campanelli, R.4
Robustelli Della Cuna, G.5
Gennari, R.6
-
52
-
-
84908431010
-
Profiling the T-cell receptor repertoire of patient with pleural tuberculosis by high-throughput sequencing
-
Li D, Gao G, Li Z, Sun W, Li X, Chen N, et al. Profiling the T-cell receptor repertoire of patient with pleural tuberculosis by high-throughput sequencing. Immunol Lett 2014;162:170-80.
-
(2014)
Immunol Lett
, vol.162
, pp. 170-180
-
-
Li, D.1
Gao, G.2
Li, Z.3
Sun, W.4
Li, X.5
Chen, N.6
-
53
-
-
84928912377
-
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: Long-term follow-up and correlates with response
-
Robbins PF, Kassim SH, Tran TL, Crystal JS, Morgan RA, Feldman SA, et al. A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response. Clin Cancer Res 2015;21:1019-27.
-
(2015)
Clin Cancer Res
, vol.21
, pp. 1019-1027
-
-
Robbins, P.F.1
Kassim, S.H.2
Tran, T.L.3
Crystal, J.S.4
Morgan, R.A.5
Feldman, S.A.6
-
54
-
-
32244442535
-
Design and use of conditional MHC class I ligands
-
Toebes M, Coccoris M, Bins A, Rodenko B, Gomez R, Nieuwkoop NJ, et al. Design and use of conditional MHC class I ligands. Nat Med 2006;12:246-51.
-
(2006)
Nat Med
, vol.12
, pp. 246-251
-
-
Toebes, M.1
Coccoris, M.2
Bins, A.3
Rodenko, B.4
Gomez, R.5
Nieuwkoop, N.J.6
-
55
-
-
0034781060
-
Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay
-
Becker C, Pohla H, Frankenberger B, Schuler T, Assenmacher M, Schendel DJ, et al. Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. Nat Med 2001;7:1159-62.
-
(2001)
Nat Med
, vol.7
, pp. 1159-1162
-
-
Becker, C.1
Pohla, H.2
Frankenberger, B.3
Schuler, T.4
Assenmacher, M.5
Schendel, D.J.6
-
56
-
-
84892711807
-
Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy
-
Turcotte S, Gros A, Tran E, Lee CC, Wunderlich JR, Robbins PF, et al. Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy. Clin Cancer Res 2014;20:331-43.
-
(2014)
Clin Cancer Res
, vol.20
, pp. 331-343
-
-
Turcotte, S.1
Gros, A.2
Tran, E.3
Lee, C.C.4
Wunderlich, J.R.5
Robbins, P.F.6
-
57
-
-
47649122633
-
Tumor-specific Th17-polarized cells eradicate large established melanoma
-
Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A, et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 2008;112:362-73.
-
(2008)
Blood
, vol.112
, pp. 362-373
-
-
Muranski, P.1
Boni, A.2
Antony, P.A.3
Cassard, L.4
Irvine, K.R.5
Kaiser, A.6
-
58
-
-
45549099784
-
Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1
-
Hunder NN, Wallen H, Cao J, Hendricks DW, Reilly JZ, Rodmyre R, et al. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med 2008;358:2698-703.
-
(2008)
N Engl J Med
, vol.358
, pp. 2698-2703
-
-
Hunder, N.N.1
Wallen, H.2
Cao, J.3
Hendricks, D.W.4
Reilly, J.Z.5
Rodmyre, R.6
-
59
-
-
84928811341
-
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
-
Kreiter S, Vormehr M, van de Roemer N, Diken M, Lower M, Diekmann J, et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature 2015;520:692-96.
-
(2015)
Nature
, vol.520
, pp. 692-696
-
-
Kreiter, S.1
Vormehr, M.2
Van De Roemer, N.3
Diken, M.4
Lower, M.5
Diekmann, J.6
-
60
-
-
84940886063
-
Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer
-
Bacher P, Jochheim-Richter A, Mockel-Tenbrink N, Kniemeyer O, Wingenfeld E, Alex R, et al. Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer. Cytotherapy 2015;17:1396-405.
-
(2015)
Cytotherapy
, vol.17
, pp. 1396-1405
-
-
Bacher, P.1
Jochheim-Richter, A.2
Mockel-Tenbrink, N.3
Kniemeyer, O.4
Wingenfeld, E.5
Alex, R.6
-
61
-
-
8444234229
-
4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses
-
Dawicki W, Bertram EM, Sharpe AH, Watts TH. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses. J Immunol 2004;173:5944-51.
-
(2004)
J Immunol
, vol.173
, pp. 5944-5951
-
-
Dawicki, W.1
Bertram, E.M.2
Sharpe, A.H.3
Watts, T.H.4
-
62
-
-
0036909587
-
Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses
-
Taraban VY, Rowley TF, O'Brien L, Chan HT, Haswell LE, Green MH, et al. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses. Eur J Immunol 2002;32:3617-27.
-
(2002)
Eur J Immunol
, vol.32
, pp. 3617-3627
-
-
Taraban, V.Y.1
Rowley, T.F.2
O'Brien, L.3
Chan, H.T.4
Haswell, L.E.5
Green, M.H.6
-
63
-
-
84902148239
-
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
-
Van Allen EM, Wagle N, Stojanov P, Perrin DL, Cibulskis K, Marlow S, et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med 2014;20:682-88.
-
(2014)
Nat Med
, vol.20
, pp. 682-688
-
-
Van Allen, E.M.1
Wagle, N.2
Stojanov, P.3
Perrin, D.L.4
Cibulskis, K.5
Marlow, S.6
-
64
-
-
84961734855
-
The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens
-
Lee HB, Joung JG, Kim J, Lee KM, Ryu HS, Lee HO, et al. The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens. Cancer Cytopathol 2015;123:669-77.
-
(2015)
Cancer Cytopathol
, vol.123
, pp. 669-677
-
-
Lee, H.B.1
Joung, J.G.2
Kim, J.3
Lee, K.M.4
Ryu, H.S.5
Lee, H.O.6
-
65
-
-
84877579861
-
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
-
Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 2013;497:108-12.
-
(2013)
Nature
, vol.497
, pp. 108-112
-
-
Murtaza, M.1
Dawson, S.J.2
Tsui, D.W.3
Gale, D.4
Forshew, T.5
Piskorz, A.M.6
-
66
-
-
84900333051
-
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
-
Lohr JG, Adalsteinsson VA, Cibulskis K, Choudhury AD, Rosenberg M, Cruz-Gordillo P, et al. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotechnol 2014;32:479-84.
-
(2014)
Nat Biotechnol
, vol.32
, pp. 479-484
-
-
Lohr, J.G.1
Adalsteinsson, V.A.2
Cibulskis, K.3
Choudhury, A.D.4
Rosenberg, M.5
Cruz-Gordillo, P.6
|